Denali Therapeutics Inc. (DNLI) closed the last trading session at $21.64, gaining 2.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $38.87 indicates a 79.6% upside potential. The mean estimate comprises 15 short-term price targets with a standard deviation of $16.35. While the lowest estimate of $22 indicates a 1.7% increase from the current price level, the most optimistic ana ...